Extracorporeal Shockwave and Myofascial Release Therapy in Chronic Pelvic Pain Syndrome
Unknown statusNot applicableNCT05659199
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The primary aims of this research are three folds: (1) To identify more relatively effective interventions for improving pain symptoms in CP/CPPS patients. (2) To ascertain the correlation between PFM elastic modulus and tenderness symptoms. This may find a more objective method of assessing efficacy. (3) To determine the correlation between the intensity of the sympathetic response and the patient's symptoms and to explore other possible pathogenetic mechanisms.
Study details
- Official title
- Study on the Intervention of Extracorporeal Shockwave Therapy and Myofascial Release Therapy in Chronic Pelvic Pain Syndrome
- Conditions
- Interventions
- Device: extracorporeal shockwave
- Behavioral: myofascial release
- Sponsor
- Zongda Hospital affiliated to Southeast University
- Start date
- 2023-01-01
- Primary completion
- 2023-12-31
- Sex
- Male
- Age range
- from 20 Years to 40 Years
- Results posted
- No results posted in this snapshot
- Countries
- China
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * ① According to the National Institutes of Health classification of prostatitis\[27\], all male patients meet the diagnostic criteria for chronic prostatitis type IIIB/chronic pelvic pain syndrome (pain in the bladder, groin, perineal area, genitalia or lower abdomen with no significant abnormalities on urological examination); * Patients are aged 20-40 years; * Patients with Chronic pelvic pain lasting over 6 months； ④ Patients sign the informed consent form. Exclusion Criteria: * ① Patients with significant coagulation disorders, perineal anatomical abnormalities, hormonal abnormalities and neurological abnormalities; * Patients with a clear cause of pelvic pain, such as a history of previous surgery, chronic infection, trauma, prostatitis and epididymitis; * Patients receiving other treatments during the study; ④ Patients with any urethral pathology; * Patients who have had closed lumbar injections and previous lumbar surgery within six months; * Patients with other conditions causing pelvic pain; ⑦ Patients with contraindications to physiotherapy; ⑧ BMI\>22.9
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05659199